HomeNXG • CVE
add
NexgenRx Inc
Previous close
$0.28
Year range
$0.23 - $0.35
Market cap
19.93M CAD
Avg Volume
5.72K
P/E ratio
31.64
Dividend yield
3.57%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 4.55M | 8.14% |
Operating expense | 3.07M | 5.15% |
Net income | 527.21K | 14.37% |
Net profit margin | 11.59 | 5.84% |
Earnings per share | — | — |
EBITDA | 832.52K | 4.28% |
Effective tax rate | -4.53% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.90M | 39.28% |
Total assets | 32.61M | 11.33% |
Total liabilities | 24.49M | 16.52% |
Total equity | 8.12M | — |
Shares outstanding | 71.12M | — |
Price to book | 3.11 | — |
Return on assets | 4.36% | — |
Return on capital | 16.38% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 527.21K | 14.37% |
Cash from operations | 352.58K | 166.97% |
Cash from investing | -95.63K | -57.93% |
Cash from financing | -66.97K | -193.96% |
Net change in cash | 189.98K | 136.84% |
Free cash flow | 123.53K | 117.58% |
About
Founded
2003
Headquarters
Website
Employees
20
